Integra LifeSciences Holdings Corporation (IART)
NASDAQ: IART · Real-Time Price · USD
16.79
+0.09 (0.54%)
Apr 25, 2025, 4:00 PM EDT - Market closed
IART Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for IART stock have an average target of 24.33, with a low estimate of 18 and a high estimate of 35. The average target predicts an increase of 44.91% from the current stock price of 16.79.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for IART stock from 8 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 0 | 1 | 1 |
| Buy | 2 | 2 | 2 | 1 | 1 | 1 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 2 | 2 | 2 | 2 | 2 | 2 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 9 | 9 | 9 | 7 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Hold Maintains $26 → $19 | Hold | Maintains | $26 → $19 | +13.16% | Apr 11, 2025 |
| Argus Research | Argus Research | Hold → Strong Buy Upgrades n/a | Hold → Strong Buy | Upgrades | n/a | n/a | Mar 31, 2025 |
| Citizens Capital Markets | Citizens Capital Markets | Buy Reiterates $35 | Buy | Reiterates | $35 | +108.46% | Feb 26, 2025 |
| Citigroup | Citigroup | Strong Sell Maintains $16 → $22 | Strong Sell | Maintains | $16 → $22 | +31.03% | Nov 5, 2024 |
| Truist Securities | Truist Securities | Hold Maintains $26 → $21 | Hold | Maintains | $26 → $21 | +25.07% | Oct 14, 2024 |
Financial Forecast
Revenue This Year
1.71B
from 1.61B
Increased by 6.36%
Revenue Next Year
1.79B
from 1.71B
Increased by 4.32%
EPS This Year
2.51
from -0.09
EPS Next Year
2.77
from 2.51
Increased by 10.40%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 1.8B | 1.9B | 1.9B |
| Avg | 1.7B | 1.8B | 1.9B |
| Low | 1.6B | 1.7B | 1.8B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 9.9% | 8.4% | 8.1% |
| Avg | 6.4% | 4.3% | 4.0% |
| Low | 1.6% | -1.3% | -0.8% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 2.60 | 2.99 | 3.33 |
| Avg | 2.51 | 2.77 | 3.10 |
| Low | 2.39 | 2.62 | 2.89 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | 19.2% | 20.1% |
| Avg | - | 10.4% | 11.9% |
| Low | - | 4.2% | 4.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.